Comparison
BPC-157 vs TB-500
Which recovery peptide is right for you — and do you actually need to choose?
Quick answer
BPC-157 works best for targeted, local healing — tendons, ligaments, gut, and specific injury sites. TB-500 works systemically, improving flexibility and reducing inflammation throughout the entire body. Most serious users run both together because they work through completely different mechanisms and complement each other well.
BPC-157
Body Protection Compound
Best for
Targeted injury repair
Dose
250-500mcg/day
Route
SubQ injection near injury site
Half-life
~4 hours
TB-500
Thymosin Beta-4 fragment
Best for
Systemic recovery
Dose
2.5mg twice per week
Route
SubQ injection anywhere
Half-life
Unknown (long acting)
How they work differently
BPC-157 is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Its primary mechanism is promoting angiogenesis — the formation of new blood vessels — in damaged tissue. When injected near an injury site, it accelerates the delivery of oxygen and nutrients to the area, dramatically speeding up tendon, ligament, and muscle repair. It also has a strong affinity for gut tissue, making it the go-to peptide for GI issues ranging from leaky gut to NSAID-induced ulcers.
TB-500 works through a completely different pathway. It is a synthetic fragment of Thymosin Beta-4, a protein naturally produced in high concentrations at injury sites. TB-500 promotes actin upregulation — actin is the protein that makes up the cellular scaffolding of muscle and connective tissue. By increasing actin availability, TB-500 accelerates cell migration and tissue remodeling across the entire body, not just at the injection site. This systemic action is what makes it uniquely effective for improving overall flexibility and reducing widespread inflammation.
The key practical difference
The most important difference for most users is local vs systemic action. BPC-157 is significantly more effective when injected near the injury. If you have a torn rotator cuff, injecting BPC-157 subcutaneously near the shoulder concentrates the healing effect where you need it. Injecting it in your stomach still has some systemic effect, but the local advantage is real and documented.
TB-500 does not have this site-specific advantage — or disadvantage. You can inject it anywhere and it works throughout the body. This makes it more convenient for people uncomfortable with injecting near sensitive areas, and more practical for people dealing with multiple issues simultaneously. If you have shoulder pain, knee stiffness, and general fatigue from training, TB-500 addresses all of them with one protocol.
Which one should you choose?
If your goal is: Single acute injury (tendon, ligament tear)
→ Choose BPC-157
Local injection near the site gives a significantly stronger healing effect for targeted tissue damage.
If your goal is: General inflammation and stiffness across multiple areas
→ Choose TB-500
Systemic action addresses the whole body rather than one specific spot.
If your goal is: Gut issues (IBS, leaky gut, NSAID damage)
→ Choose BPC-157
Has the strongest evidence for GI repair of any peptide. TB-500 has minimal gut-specific research.
If your goal is: Improving flexibility and range of motion
→ Choose TB-500
The actin upregulation mechanism specifically improves tissue elasticity and flexibility.
If your goal is: Maximum recovery — serious athletes or post-surgery
→ Choose Both together
They work through different pathways and stack synergistically. The combined protocol is the most commonly reported approach in experienced communities.
Running them together
The most popular protocol in recovery communities combines both peptides because they genuinely complement each other. BPC-157 handles the acute, targeted repair while TB-500 addresses systemic inflammation and flexibility. A common starting protocol looks like this:
Combined recovery protocol:
BPC-157: 250-500mcg/day — SubQ near injury site
TB-500: 2.5mg twice per week — SubQ anywhere
Duration: 8-12 weeks
Evidence quality
Neither peptide has robust human clinical trial data, which is the honest truth that most sites gloss over. The majority of evidence for both comes from animal studies — rats and horses primarily. The animal data is compelling and consistent, but extrapolating to humans requires caution.
Anecdotal human evidence across peptide communities is substantial for both, particularly for BPC-157 in tendon recovery and TB-500 for flexibility. The risk profiles appear low based on reported human use, but formal long-term safety data does not exist. Both are sold as research chemicals and are not FDA approved for human use.
Cost comparison
BPC-157 typically runs $40-60 per 5mg vial from reputable vendors. At 250mcg/day that is about 20 doses per vial, roughly $2-3 per day. TB-500 is more expensive per vial at $55-65 for 5mg, but at 2.5mg twice weekly you use one vial over about a week. Monthly cost for the combined protocol from quality vendors runs $150-250 depending on sourcing. See our vendor rankings for current pricing.